New pill aims to quiet Schizophrenia's worst symptoms
NCT ID NCT07038876
First seen Oct 31, 2025 · Last updated May 15, 2026 · Updated 32 times
Summary
This study tests an experimental oral medication, ML-007C-MA, against a placebo in 300 adults hospitalized for a sudden worsening of schizophrenia symptoms. The goal is to see if the drug safely reduces psychosis severity, measured by a standard symptom scale. Participants must be 18-64 years old and currently experiencing an acute episode.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Clinical Site
RECRUITINGLittle Rock, Arkansas, 72211, United States
-
Clinical Site
RECRUITINGBellflower, California, 90706, United States
-
Clinical Site
RECRUITINGCulver City, California, 90230, United States
-
Clinical Site
RECRUITINGGarden Grove, California, 92845, United States
-
Clinical Site
RECRUITINGLemon Grove, California, 91945, United States
-
Clinical Site
RECRUITINGLos Angeles, California, 90015, United States
-
Clinical Site
ACTIVE_NOT_RECRUITINGMontclair, California, 91763, United States
-
Clinical Site
RECRUITINGOrange, California, 92868, United States
-
Clinical Site
RECRUITINGRiverside, California, 92506, United States
-
Clinical Site
RECRUITINGSan Diego, California, 92123, United States
-
Clinical Site
WITHDRAWNSantee, California, 92071, United States
-
Clinical Site
RECRUITINGSherman Oaks, California, 91403, United States
-
Clinical Site
RECRUITINGTorrance, California, 90504, United States
-
Clinical Site
RECRUITINGHollywood, Florida, 33024, United States
-
Clinical Site
ACTIVE_NOT_RECRUITINGMiami Lakes, Florida, 33016, United States
-
Clinical Site
RECRUITINGWest Palm Beach, Florida, 33407, United States
-
Clinical Site
RECRUITINGAtlanta, Georgia, 30331, United States
-
Clinical Site
ACTIVE_NOT_RECRUITINGDecatur, Georgia, 30030, United States
-
Clinical Site
RECRUITINGChicago, Illinois, 60640, United States
-
Clinical Site
RECRUITINGMarlton, New Jersey, 08053, United States
-
Clinical Site
RECRUITINGStaten Island, New York, 10314, United States
-
Clinical Site
RECRUITINGNorth Canton, Ohio, 44720, United States
-
Clinical Site
RECRUITINGAustin, Texas, 78754, United States
-
Clinical Site
RECRUITINGDeSoto, Texas, 75115, United States
-
Clinical Site
RECRUITINGRichardson, Texas, 75080, United States
Conditions
Explore the condition pages connected to this study.